Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
42.82
+0.02 (0.05%)
At close: May 29, 2026, 4:00 PM EDT
42.75
-0.07 (-0.16%)
After-hours: May 29, 2026, 7:13 PM EDT

Sionna Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-85.57-75.27-61.69-47.26-40.24
Depreciation & Amortization
0.640.650.670.580.12
Stock-Based Compensation
16.5312.073.712.261.69
Other Adjustments
-0.6-1.097.61.51-0.4
Changes in Accounts Payable
-2.76-0.420.470.16-1.51
Changes in Accrued Expenses
-2.071.981.08-1.115.03
Changes in Other Operating Activities
-2.93-4.21-4.620.16-0.75
Operating Cash Flow
-71.85-66.3-52.79-43.7-36.07
Capital Expenditures
-0.29-0.38-0.03-1.12-1.87
Purchases of Investments
-178.76-325.03-182.84-23.53-40.39
Proceeds from Sale of Investments
226.31206.6555.965213
Investing Cash Flow
47.27-118.75-126.9127.35-29.26
Issuance of Common Stock
5.53205.710.140.030.06
Net Common Stock Issued (Repurchased)
5.53205.710.140.030.06
Issuance of Preferred Stock
--181.33-110.79
Net Preferred Stock Issued (Repurchased)
--181.33-110.79
Other Financing Activities
-0.32--2.5--
Financing Cash Flow
5.21205.71178.970.03110.86
Net Cash Flow
-19.3720.66-0.73-16.3245.52
Free Cash Flow
-72.14-66.67-52.81-44.82-37.94
Free Cash Flow Per Share
-1.62-1.67-13.69-15.28-0.01
Levered Free Cash Flow
-92.97-77.65-64.12-48.58-39.23
Unlevered Free Cash Flow
-106.33-91.36-72.99-51.65-40.36
SEC Filings: 10-K · 10-Q